|
(1/2) University of Guam/University of Hawaii Cancer Center Partnership
|
5U54CA143727-07
|
$1,275,740
|
PALAFOX, NEAL
|
UNIVERSITY OF HAWAII AT MANOA
|
|
(2/2) CDU/UCLA Cancer Center Partnership to Eliminate Cancer Health Disparities
|
5U54CA143930-07
|
$730,767
|
FARIAS-EISNER, ROBIN
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
(PQ#9)Targeting leaky ryanodine receptor (RyR2) to treat and prevent chemotherapy-associated cognitive dysfunction in patients with breast cancer.
|
1R01CA206025-01
|
$655,037
|
GUISE, THERESA
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
(PQ6) Molecular Mechanisms Driving Benign to Malignant Transitions in Breast Cancer
|
1R01CA205632-01
|
$469,489
|
RIEGEL, ANNA
|
GEORGETOWN UNIVERSITY
|
|
(PQ7) Quantitative in vivo optical imaging of tumor heterogeneity
|
1R01CA205101-01
|
$406,070
|
SKALA, MELISSA
|
MORGRIDGE INSTITUTE FOR RESEARCH, INC.
|
|
(PQ8) BONE MARROW-ON-A-CHIP"":AN INVITRO 3D MODEL OF BREAST CANCER DORMANCY
|
1R21CA208519-01
|
$165,844
|
GEORGE, STEVEN
|
WASHINGTON UNIVERSITY
|
|
(PQ9) A novel mechanism of paclitaxel-induced peripheral neuropathy and potential treatment
|
1R01CA208765-01
|
$351,874
|
YANG, QING
|
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
|
|
(PQ9) Characterization and prophylactic treatment of chemotherapy-induced long-term adverse sequelae
|
1R01CA208634-01
|
$560,277
|
JURECIC, ROLAND
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
(PQ9) Dual Action RSK Inhibitor: Targeting Metastasis and Providing Cardioprotection
|
1R21CA208631-01
|
$251,120
|
LANNIGAN, DEBORAH
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
(PQ9) Novel therapeutic approaches to chemotherapy-induced muscle
|
7R21CA205437-02
|
$152,333
|
WANING, DAVID
|
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
|
|
(PQ9) Novel therapeutic approaches to chemotherapy-induced muscle.
|
1R21CA205437-01
|
$51,247
|
WANING, DAVID
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
(PQ9) The role of Bclw (bcl2l2) in preventing chemotherapy induced neuropathy
|
1R01CA205255-01
|
$577,463
|
SEGAL, ROSALIND
|
DANA-FARBER CANCER INST
|
|
(PQA-5) DNA methylation and cancer prevention: duration and intensity of exercise
|
4R01CA179963-04
|
$513,435
|
BRYAN, ANGELA
|
UNIVERSITY OF COLORADO
|
|
(PQA1)Molecular mechanisms by which the diabetic drug metformin kills cancer cell
|
4R01CA180033-04
|
$295,065
|
MISKIMINS, W
|
SANFORD RESEARCH/USD
|
|
(PQA2) Exploring the role of sarcopenia in obesity and breast cancer survival
|
5R01CA184953-03
|
$602,462
|
CAAN, BETTE
|
KAISER FOUNDATION RESEARCH INSTITUTE
|
|
(PQA2) Interstitial stiffness as a physicochemical modulator of obesity-induced b
|
5R01CA185293-03
|
$329,112
|
FISCHBACH, CLAUDIA
|
CORNELL UNIVERSITY
|
|
(PQA2) MAMMALIAN REGENERATION, HIGH FAT DIETS, AND BREAST CANCER: A COMMON LINK?
|
5R01CA180070-05
|
$339,116
|
HEBER-KATZ, ELLEN
|
LANKENAU INSTITUTE FOR MEDICAL RESEARCH
|
|
(PQA2): Escape from breast tumor dormancy: convergence of obesity and menopause
|
5R01CA185530-03
|
$367,275
|
MOSES, MARSHA
|
CHILDREN'S HOSPITAL CORPORATION
|
|
(PQA4) GPS exposure to environments & relations with biomarkers of cancer risk
|
4R01CA179977-04
|
$816,993
|
KERR, JACQUELINE
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
(PQB-4) Opposing Effects of the SASP in Cancer Progression
|
5R01CA184572-03
|
$329,925
|
HERBIG, UTZ
|
RBHS-NEW JERSEY MEDICAL SCHOOL
|
|
(PQB4) Stochastic Profiling of Functional Single-Cell States Within Solid Tumors
|
5R01CA194470-02
|
$464,569
|
JANES, KEVIN
|
UNIVERSITY OF VIRGINIA
|
|
(PQC2)Nanoscale changes in 3D nuclear architecture during breast tumorigenesis
|
5R01CA185363-03
|
$318,250
|
LIU, YANG
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
(PQC3) Ethnicity-determined immune response and DCIS outcome
|
5R01CA194600-02
|
$684,967
|
BADVE, SUNIL
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
(PQC3) Genomic Diversity and Microenvironment as Drivers of Metastasis in DCIS
|
5R01CA185138-03
|
$490,842
|
HWANG, EUN-SIL
|
DUKE UNIVERSITY
|
|
(PQC4) Fate of cells disseminating from human breast cancer xenografts
|
4R01CA180039-04
|
$328,888
|
WERB, ZENA
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
(PQC6) Molecular Determinants of Quiescent Cancer Cells
|
5R01CA185086-03
|
$488,316
|
RAMASWAMY, SRIDHAR
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
(PQD-3) Spatiotemporal Molecular Interrogation of Early Metastatic Evolution In Situ
|
5R01CA194697-02
|
$347,700
|
ZHANG, SIYUAN
|
UNIVERSITY OF NOTRE DAME
|
|
(PQD4) SIGNS OF INFLAMMATORY BREAST CANCER ARE CAUSED BY STROMAL FIELD EFFECTS
|
4R01CA180061-04
|
$410,757
|
WOODWARD, WENDY
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
(PQE3)A Statewide RCT to Reduce Use of Ineffective or Unproven Breast Cancer Care
|
5R01CA190016-03
|
$802,301
|
NATTINGER, ANN
|
MEDICAL COLLEGE OF WISCONSIN
|
|
1 of 3 Interdisciplinary Collaboratory for Enhancing Translational Therapeutics Utilizing Biologically, Immunologically, and Metabollically Relevant Models of Breast Cancer
|
5R01CA195904-02
|
$568,802
|
MURPHY, WILLIAM
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
1/2 NCCU-DUKE Cancer Disparities Translational Research Partnership
|
1P20CA202924-01A1
|
$234,900
|
WILLIAMS, KEVIN
|
NORTH CAROLINA CENTRAL UNIVERSITY
|
|
1/2 SDSU/UCSD Cancer Center Comprehensive Partnership
|
5U54CA132379-07
|
$1,293,750
|
MARTINEZ, MARIA
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
1/2 The GUIDE Cancer Research Training Project
|
5P20CA202908-02
|
$224,260
|
WINN, ROBERT
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
1/3: The Chicago Collaborative to Promote and Advance Cancer Health Equity
|
3U54CA203000-02S1
|
$25,000
|
SIMON, MELISSA
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
1/3: The Chicago Collaborative to Promote and Advance Cancer Health Equity
|
5U54CA203000-02
|
$1,377,921
|
SIMON, MELISSA
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
2/2 NCCU-DUKE Cancer Disparities Translational Research Partnership
|
1P20CA202925-01A1
|
$259,367
|
PATIERNO, STEVEN
|
DUKE UNIVERSITY
|
|
2/2 NCCU-LCCC Partnership in Cancer Research
|
5U54CA156733-07
|
$997,277
|
EARP, HENRY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
2/2 The GUIDE Cancer Research Training Project
|
3P20CA202907-02S1
|
$52,412
|
BALTHAZAR, CATHERINE
|
GOVERNORS STATE UNIVERSITY
|
|
2/2 The GUIDE Cancer Research Training Project
|
5P20CA202907-02
|
$174,056
|
BALTHAZAR, CATHERINE
|
GOVERNORS STATE UNIVERSITY
|
|
2/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama Ca Ctr Partnership
|
2U54CA118623-11
|
$1,134,399
|
TROY, ROBERTA
|
TUSKEGEE UNIVERSITY
|
|
2/3: The Chicago Collaborative to Promote and Advance Cancer Health Equity
|
3U54CA202995-02S1
|
$39,000
|
CIECIERSKI, CHRISTINA
|
NORTHEASTERN ILLINOIS UNIVERSITY
|
|
2/3: The Chicago Collaborative to Promote and Advance Cancer Health Equity
|
5U54CA202995-02
|
$829,677
|
CIECIERSKI, CHRISTINA
|
NORTHEASTERN ILLINOIS UNIVERSITY
|
|
27-hydroxycholesterol as a link between obesity and breast cancer pathogenesis
|
5R00CA172357-05
|
$240,780
|
NELSON, ERIK
|
UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
|
|
3-D modeling-based decision support for optimizing quality of life following breast reconstruction
|
1R01CA203984-01
|
$687,629
|
MARKEY, MIA
|
UNIVERSITY OF TEXAS, AUSTIN
|
|
3-dimensional circulating miRNA expression profile for early breast cancer detection
|
3R01CA188991-02S1
|
$55,906
|
ZHONG, WENWAN
|
UNIVERSITY OF CALIFORNIA RIVERSIDE
|
|
3-Dimensional profile of circulating miRNA for early cancer detection
|
5R01CA188991-02
|
$308,434
|
ZHONG, WENWAN
|
UNIVERSITY OF CALIFORNIA RIVERSIDE
|
|
3/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama Ca Ctr Partnership
|
2U54CA118948-11
|
$1,337,658
|
MANNE, UPENDER
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
3/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama Ca Ctr Partnership
|
3U54CA118948-11S1
|
$162,279
|
MANNE, UPENDER
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
3/3: The Chicago Collaborative to Promote and Advance Cancer Health Equity
|
3U54CA202997-02S1
|
$250,000
|
WINN, ROBERT
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
3/3: The Chicago Collaborative to Promote and Advance Cancer Health Equity
|
5U54CA202997-02
|
$1,291,853
|
WINN, ROBERT
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|